COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE

Abstract: the present disclosure relates generally to methods of using inhibitors of tumor progression locus 2 (tpl2) kinase for treating, stabilizing, or lessening the severity or progression of inflammatory bowel disease (ibd), including crohn's disease (cd) and ulcerative colitis (uc), and pharmaceutical compositions including tpl2 kinase inhibitors for use in such methods.

Inventor(s): Elijah J. Weber, Ahmed A. Othman, Ingrid J. Chang, Matthew T. McKevitt

CPC Classification: A61K31/4725 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250213550